GeneBioTech Co. ,Ltd (KOSDAQ:086060)

GeneBioTech Co. ,Ltd Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	43,311	28,329	37,542	34,356	45,119	49,511
Market Cap Growth	46.86%	-24.54%	9.27%	-23.86%	-8.87%	2.31%
Enterprise Value	35,299	19,776	30,940	31,105	35,590	41,859
Last Close Price	5030.00	3249.43	4306.24	3940.80	5175.39	5679.10
PE Ratio	11.77	9.89	14.49	22.55	-	-
PS Ratio	0.47	0.34	0.47	0.42	0.72	0.84
PB Ratio	0.80	0.56	0.78	0.75	1.03	0.98
P/TBV Ratio	0.81	0.56	0.79	0.77	1.05	1.12
P/FCF Ratio	30.37	-	5.49	-	-	-
P/OCF Ratio	7.66	-	5.10	-	-	19.87
EV/Sales Ratio	0.38	0.24	0.39	0.38	0.57	0.71
EV/EBITDA Ratio	6.08	3.79	5.83	10.94	44.98	44.05
EV/EBIT Ratio	7.97	5.15	7.79	19.98	-	-
EV/FCF Ratio	24.75	-	4.52	-	-	-
Debt / Equity Ratio	0.26	0.31	0.26	0.28	0.23	0.11
Debt / EBITDA Ratio	2.43	3.05	2.35	4.58	13.02	5.90
Debt / FCF Ratio	9.90	-	1.83	-	-	-
Net Debt / Equity Ratio	-0.15	-0.15	-0.20	-0.07	-0.17	-0.43
Net Debt / EBITDA Ratio	-1.38	-1.44	-1.79	-1.08	-9.46	-22.93
Net Debt / FCF Ratio	-5.62	4.81	-1.39	0.63	1.29	11.50
Asset Turnover	1.25	1.20	1.22	1.33	1.03	0.91
Inventory Turnover	4.91	4.37	4.35	4.97	4.59	4.69
Quick Ratio	2.44	2.02	2.33	1.91	1.99	4.44
Current Ratio	3.53	3.04	3.40	2.91	2.98	5.92
Return on Equity (ROE)	7.05%	5.77%	5.51%	3.40%	-1.03%	-0.13%
Return on Assets (ROA)	3.77%	3.48%	3.82%	1.56%	-0.46%	-1.05%
Return on Invested Capital (ROIC)	7.71%	7.65%	7.49%	3.30%	-1.39%	-3.41%
Return on Capital Employed (ROCE)	7.40%	7.20%	7.70%	3.20%	-1.00%	-2.00%
Earnings Yield	8.50%	10.11%	6.90%	4.43%	-1.07%	-4.73%
FCF Yield	3.29%	-5.52%	18.21%	-14.07%	-12.89%	-3.83%
Dividend Yield	0.99%	-	-	-	-	0.53%
Buyback Yield / Dilution	-0.03%	-	-	-	-	-
Total Shareholder Return	0.96%	-	-	-	-	0.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.